Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 20022809

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2010 Feb
First author
Mitsudomi T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2010 Feb;11(2):104-5. doi: 10.1016/S1470-2045(09)70390-0.
    note
    Source null
    related pmid
    20152760
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2010 May;11(5):412-3; author reply 413. doi: 10.1016/S1470-2045(10)70065-6.
    note
    Source null
    related pmid
    20434712
    relationship
    Comment in

Authors and identifiers

  1. name
    Mitsudomi T
    type
    Author
  2. name
    Morita S
    type
    Author
  3. name
    Yatabe Y
    type
    Author
  4. name
    Negoro S
    type
    Author
  5. name
    Okamoto I
    type
    Author
  6. name
    Tsurutani J
    type
    Author
  7. name
    Seto T
    type
    Author
  8. name
    Satouchi M
    type
    Author
  9. name
    Tada H
    type
    Author
  10. name
    Hirashima T
    type
    Author
  11. name
    Asami K
    type
    Author
  12. name
    Katakami N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mitsudomi T
    type
    Author
  2. name
    Morita S
    type
    Author
  3. name
    Yatabe Y
    type
    Author
  4. name
    Negoro S
    type
    Author
  5. name
    Okamoto I
    type
    Author
  6. name
    Tsurutani J
    type
    Author
  7. name
    Seto T
    type
    Author
  8. name
    Satouchi M
    type
    Author
  9. name
    Tada H
    type
    Author
  10. name
    Hirashima T
    type
    Author
  11. name
    Asami K
    type
    Author
  12. name
    Katakami N
    type
    Author
bibliography ids
  1. nci-bib-57706369fea824dc1406cdab
book metadata
content sha256
134c5aa34d6d7dbd859b2d6ece816a36653a47d3c90b2879d46298cfecb71fd0
document type
citation
dois
  1. 10.1016/S1470-2045(09)70364-X
electronic publication date
display
2009 Dec 18
precision
day
year
2009
evidence scope
bibliographic_metadata_only
id
pubmed:20022809
immutable id
pubmed:20022809@134c5aa34d6d7dbd859b2d6ece816a36653a47d3c90b2879d46298cfecb71fd0
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
2
name
The Lancet. Oncology
nlm unique id
100957246
pages
121-8
volume
11
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2010 Feb;11(2):104-5. doi: 10.1016/S1470-2045(09)70390-0.
    note
    Source null
    related pmid
    20152760
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2010 May;11(5):412-3; author reply 413. doi: 10.1016/S1470-2045(10)70065-6.
    note
    Source null
    related pmid
    20434712
    relationship
    Comment in
outcomes validated
false
pmid
20022809
provenance
batch id
708c7929ee1eff455330
provider
NCBI PubMed ESummary
record sha256
90a55f92c1b469d942836a11b3dd74b8ecdb2b7269b6704fe3e20a8b893a3878
response sha256
d245af3dbc636ffc79325b3798c7bfda16faf0a3d796681b12b8d89bd68eb450
retrieved at
2026-09-09T23:46:31.496840+00:00
publication date
display
2010 Feb
precision
month
year
2010
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20022809/
title
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.

Preserved source evidence · Not medical advice